An engineered tetra-valent antibody fully activates the Tie2 receptor with comparable potency to its natural ligand angiopoietin-1
Crossref DOI link: https://doi.org/10.1038/s41598-021-93660-4
Published Online: 2021-07-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koya, Yukari
Nara, Hiromi
Yagi, Shigenori
Ueno, Chihoko
Kamohara, Masazumi
Text and Data Mining valid from 2021-07-07
Version of Record valid from 2021-07-07
Article History
Received: 16 February 2021
Accepted: 29 June 2021
First Online: 7 July 2021
Competing interests
: The authors declare no competing interests.